Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600351 stock hub

SHA/600351 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600351is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.9B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600351

In the news

Latest news · SHA/600351

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E15.3

P25 23.5P50 41.3P75 83.2

ROE10.5

P25 -0.9P50 4.1P75 8.8

ROIC14.3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600351 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

241

Groups with data

Currency

CNY

Showing 241 of 241 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	3,611
Employees Change	-531%
Employees Change Percent	-12.82
Enterprise value	CNY 4B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000001CM5
Last refreshed	2026-05-10
Market cap	CNY 4.9B
Price	CNY 7.02
Price currency	CNY
Rev Per Employee	608,571.71x
Sector	Healthcare
Sic	2834
Symbol	sha/600351
Website	https://www.yabao.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.58%
EV Earnings	12.43x
EV/EBIT	11.27x
EV/EBITDA	8.11x
EV/FCF	6.93x
EV/Sales	1.81x
FCF yield	11.8%
P/B ratio	1.74x
P/E ratio	15.3x
P/S ratio	2.21x
PE Ratio10 Y	49.62x
PE Ratio3 Y	21.18x
PE Ratio5 Y	26.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.03%
EBITDA Margin	22.11%
FCF margin	26.08%
Gross margin	52.58%
Gross Profit	CNY 1.2B
Gross Profit Growth	-9.62%
Gross Profit Growth Q	-6.37%
Gross Profit Growth3 Y	-9.47%
Gross Profit Growth5 Y	-6.54%
Net Income	CNY 319.4M
Net Income Growth	34.38%
Net Income Growth Q	-0.57%
Net Income Growth Years	3%
Net Income Growth3 Y	31.43%
Net Income Growth5 Y	19.31%
Pretax Margin	16.88%
Profit Margin	14.53%
Profit Per Employee	CNY 88,454
Profitable Years	27
ROA	6.43
Roa5y	4.28
ROCE	12.28
ROE	10.49
Roe5y	6.79
ROIC	14.27
Roic5y	8.19

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.93%
Cagr15y	0.17%
Cagr1y	24.25%
Cagr20y	11.22%
Cagr3y	2.84%
Cagr5y	8.76%
Div CAGR10	17.46%
Div CAGR3	115.44%
Div CAGR5	58.49%
EPS Growth	38.14
EPS Growth Q	1.25
EPS Growth Years	3
EPS Growth3 Y	35.93
EPS Growth5 Y	21.74
FCF Growth	92.97%
FCF Growth Q	37.28%
FCF Growth3 Y	9.38%
FCF Growth5 Y	12%
OCF Growth	82.87%
OCF Growth Q	29.11%
OCF Growth10 Y	16.17%
OCF Growth3 Y	6.85%
OCF Growth5 Y	7.75%
Revenue Growth	-13.12x
Revenue Growth Q	-6.92x
Revenue Growth Years	0x
Revenue Growth3 Y	-8.02x
Revenue Growth5 Y	-4.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.64
Assets	CNY 3.3B
Cash	CNY 866.6M
Current Assets	CNY 1.6B
Current Liabilities	CNY 409.8M
Debt	CNY 36.9M
Debt EBITDA	CNY 0.08
Debt Equity	CNY 0.01
Debt FCF	CNY 0.06
Equity	CNY 2.8B
Liabilities	CNY 485M
Long Term Assets	CNY 1.7B
Long Term Liabilities	CNY 75.2M
Net Cash	CNY 829.7M
Net Cash By Market Cap	CNY 17.08
Net Cash Growth	49.61%
Net Debt EBITDA	CNY -1.71
Net Debt Equity	CNY -0.3
Net Debt FCF	CNY -1.45
Tangible Book Value	CNY 2.7B
Tangible Book Value Per Share	CNY 3.89
WACC	4.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.92
Inventory Turnover	3.15
Net Working Capital	CNY 328.8M
Quick ratio	3.05
Working Capital	CNY 1.2B
Working Capital Turnover	CNY 1.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.72%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	CNY 0.4
Dividend Years	14
Dividend Yield	5.7%
Ex Div Date	2026-02-06
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	109.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-17.72%
1Y total return	24.23%
200-day SMA	6.79
3Y total return	8.77%
50-day SMA	6.65
50-day SMA vs 200-day SMA	50under200
5Y total return	52.15%
All Time High	19.5
All Time High Change	-64%
All Time High Date	2015-06-03
All Time Low	0.95
All Time Low Change	638.95%
All Time Low Date	2006-03-20
ATR	0.19
Beta	0.13
Beta1y	0.23
Beta2y	0.47
Ch YTD	8.17
High	7.19
High52	8.68
High52 Date	2025-08-05
High52ch	-19.12%
Low	6.96
Low52	5.86
Low52 Date	2025-06-23
Low52ch	19.8%
Ma50ch	5.64%
Price vs 200-day SMA	3.36%
RSI	60.28
RSI Monthly	55.27
RSI Weekly	58.04
Sharpe ratio	0.99x
Sortino ratio	1.81
Total Return	8.42%
Tr YTD	11.42
Tr15y	2.65%
Tr1m	3.08%
Tr1w	-0.71%
Tr3m	5.41%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 352.3M
Operating Income Growth	5.09
Operating Income Growth Q	4.13
Operating Income Growth3 Y	17.23
Operating Income Growth5 Y	21.27
Operating margin	16.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	583,476,290%
Net Borrowing	-55,170,625
Shares Institutions	7.62%
Shares Out	692,000,046
Shares Qo Q	-0.07%
Shares Yo Y	-2.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 573.1M
Average Volume	26,766,830.8x
Bv Per Share	4.12
CAPEX	CNY -42.7M
Ch10y	-32.82
Ch15y	-18.84
Ch1m	3.08
Ch1w	-0.71
Ch1y	14.89
Ch20y	521.2
Ch3m	5.41
Ch3y	-2.5
Ch5y	33.46
Ch6m	2.63
Change	0.72%
Change From Open	-1.27
Close	6.97
Days Gap	2.01
Depreciation Amortization	133,580,945
Dollar Volume	175,939,171.2
Earnings Date	2026-04-25
EBIT	CNY 352.3M
EBITDA	CNY 485.9M
EPS	CNY 0.46
F Score	6
FCF	CNY 573.1M
FCF EV Yield	14.44x
FCF Per Share	CNY 0.83
Financing CF	-506,806,681
Fiscal Year End	December
Founded	1,978
Goodwill	26,268,020
Graham Number	6.52249
Graham Upside	-7.09
Income Tax	CNY 70.1M
Investing CF	117,276,644
Is Primary Listing	1
Last Earnings Date	2026-04-25
Last Report Date	2026-03-31
Last Split Date	2010-05-28
Last Split Type	Forward
Lynch Fair Value	CNY 8.86
Lynch Upside	26.21
Ma150	6.69
Ma150ch	4.96%
Ma20	6.73
Ma20ch	4.28%
Net CF	226,239,542
Next Earnings Date	2026-08-14
Open	7.11
P FCF Ratio	8.48
P OCF Ratio	7.89
Payment Date	2026-02-06
Position In Range	26.09
Ppne	1,032,591,778
Price Date	2026-05-08
Price EBITDA	CNY 10
Ptbv Ratio	1.81
Relative Volume	0.95x
Revenue	2,197,552,455x
Tax By Revenue	3.19x
Tax Rate	18.9%
Tr20y	739.35%
Tr6m	5.72%
Volume	25,062,560

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600351 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.7%

$0.40 annual per share

Payout ratio

+109.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+58.5%

2 consecutive years of growth

Total shareholder yield

+8.4%

Next ex-dividend date: 2026-02-06

Performance

SHA/600351 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600351?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.6%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-2.7%

Negative means the company is buying back shares.

Technical

SHA/600351 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.3

Neutral momentum band

Price vs 200-day MA

+3.4%

50/200-day relationship not available

Beta (5Y)

0.13

Less volatile than the market

Sharpe ratio

0.99

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600351

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600351 stock rating?

sha/600351 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600351 analysis?

The full report lives at /stocks/sha/600351/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600351?

The latest report frames sha/600351 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600351 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.